|
|
|
|
 |
| November 04,
2010 | ISSUE NUMBER 173 VOL 8 |
Regulatory
US Mid-term Elections: What It Means for Pharma
The key message coming out of the results is stalemate on the big issues like health reform rollback and deficit reduction combined with modest progress, writes William Looney.
Global
NICE News or Bad News?
Far from losing its mojo, the UK’s National Institute for Health and Clinical Excellence (NICE) will simply be sharing the stage with a range of new players under NHS reform — none of whom look supportive of the R&D industry.
Supply Chain
Report Reveals Global Supply Chain Fears
New study calls for better collaboration with suppliers, distributors, shippers, and regulators.
Strategy
Alliance Management Is Being Neglected
Survey finds disconnect between perceived importance of alliance management function at C-level and actual commitment to it.
|
|
 |
Take the Safe Path to creating ERP Value
You simply cannot afford to handle the complexities of chargebacks, scalability, and compliance with ERP “solutions” that don’t add value to your bottom line. Moving forward with a new solution? Learn how to avoid the pitfalls, and manage risk, during all stages of an ERP project, so that you can enjoy the payoffs quickly and (relatively) painlessly
 Read more...
|
CBI’s Commercialization and Market Access Congress (CMAC 2010) — 12/8-12/9, Orlando, FL
The event of the year! CMAC combines a strategic view of early-stage and launch planning with targeted programming and extensive coverage of the evolving dynamics of market access. 30+ experts from AstraZeneca, Cephalon, Daiichi, Medtronic, Mannkind, Merck, Pfizer and more! Register at  www.cmac2010.com by 11/12 and save $400 with code FET959.
|
|
Nov 16-18: Risk-Based Decision Making
Burlingame, CA
Dec 5–7: Mayo Clincil 2010 Symposium: Achieving the Vision — Advancing High-Value Health Care
Bethesda, MD
Dec 8–9: CMAC 2010 – Commercialization and Market Access Congress
Orlando, FL |
 |
|
|
|
|
|
 |
|
 |
|
 |
| Where do you see technology making the biggest impact in pharma in the next few years? |
|
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
